Table 2 Sociodemographic characteristics and diseases of plaintiffs requesting medicines from January 2003 to December 2015
Variables | n = 511 |
|---|---|
Sex n (%) | |
Male | 292 (57.1) |
Female | 219 (42.9) |
Age (years) | |
Mean (SD)a | 42.8 (24.7) |
Median (IQR)b | 43.0 (20.0–64.0) |
Income (US$) | |
Mean (SD)a | 1409.6 (1101.8) |
Median (IQR)b | 1036.9 (680.5–1506.5) |
Total costs of medications in the lawsuit (US$) | |
Mean (SD)a | 1.483.3 (4.345.7) |
Median (IQR)b | 406.2 (143.9–1198.6) |
Quantity of medications n (%) | |
Mean (SD)a | 2.9 (2.4) |
Median (IQR)b | 2.0 (1.0–4.0) |
Prescription’s origin n (%) | |
Prescribed by a SUS clinician | 77 (28.2) |
Prescribed by a private system clinician | 196 (71.8) |
Diseasesc n (%) | |
Certain infectious and parasitic diseases | 5 (1.0) |
Neoplasms | 7 (1.4) |
Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism | 4 (0.8) |
Endocrine, nutritional and metabolic diseases | 71 (13.9) |
Mental and behavioural disorders | 77 (15.1) |
Diseases of the nervous system | 84 (16.4) |
Diseases of the eye and adnexa | 17 (3.3) |
Diseases of the circulatory system | 109 (21.3) |
Diseases of the respiratory system | 17 (3.3) |
Diseases of the digestive system | 27 (5.3) |
Diseases of the musculoskeletal system and connective tissue | 28 (5.5) |
Diseases of the genitourinary system | 139 (27.2) |